CLU and neoplasm: Considering the potential role of extracellular CLU as an inhibitor of the complement (MAC insertion) as well as an inhibitor of apoptosis, it is tempting to speculate that the hypomethylated status of CLU results from the expansion of CLU-positive tumor cells selected because they are resistant to the immune pressure [105].